HD Medical’s HD Steth screens over 50,000 children for congenital heart defects

Santa Clara, California, USA:

– Smart stethoscope with built-in ECG has saved over 36 lives so far –

– Plans to expand screenings to more than 500,000 children worldwide –

In recognition of World Congenital Heart Defects (CHD) Awareness Week, HD Medical Inc. today announces that it has screened over 50,000 children for CHD using HD Steth™. These screenings have been conducted at several locations in India, helping to save over 35 lives so far. HD Medical plans to expand screenings to more than 500,000 children worldwide. Children diagnosed with coronary heart disease received life-saving treatments and surgeries by Sri Sathya Sai Sanjeevani Hospitals in India.

Coronary heart disease is the most common type of birth defect. One in 100 babies is born with coronary artery disease worldwide, and nearly 40,000 infants in the United States are born with coronary artery disease each year. In India every year about 300,000 children are born with CAD and about 25% die before their first birthday. Lack of early detection and sophisticated pediatric care causes more than 250 child deaths every day in India. Conventional stethoscopes used for screening gave 28% false positives and 51% false negatives when used by lay people and health workers. Although the ultrasound echocardiogram is a more accurate alternative, the high cost of the equipment and the low availability of trained medical professionals have limited their use.

HD Medical’s FDA-cleared HD Steth solves this problem by providing a cost-effective, easy-to-use solution for non-specialists and primary healthcare workers. HD Steth has been tested and validated by a clinical study involving 1,200 children, with a sensitivity of 91% and a specificity of 99% for the detection of heart murmurs caused by coronary artery disease compared to ultrasound echocardiograms as a gold standard. gold at Sri Sathya Sai Sanjeevani Hospital in Raipur, Chhattisgarh. Central India. Based on this study, HD Steth has been adopted in a large coronary heart disease screening program in their group hospitals and in medical screening programs at several locations in India as follows:

  • Sai Sanjeevani Hospital in Palwal, Haryana: 12,974
  • Sai Sanjeevani Hospital in Kharghar, Maharashtra: 8,020
  • Sai Sanjeevani Hospital in Raipur, Chhattisgarh: 2,000
  • Sai Sanjeevani-Niraamaya Bastar Initiative: 1,000
  • Sai Sarla Memorial Hospital, Chickaballapur, Karnataka: 19,650
  • Sai Arogya Vahini Trust Mobile Medical Clinics, Kolkata, West Bengal: 8,450
  • Total number of children screened: 52,094
  • Total number of children screened and confirmed with CHD: 90+
  • Total number of children saved through heart surgeries: 36+

Sri Sathya Sai Sanjeevani Hospitals in Maharashtra, Chhattisgarh and Haryana are India’s largest providers of totally free pediatric cardiac procedures, performing nearly 14,000 surgeries and catheters since 2012. The future in providing healthcare totally free,” said Mr. C Sreenivas, President of Sai Sanjeevani Hospitals. “HD Medical’s HD Steth device is very helpful in screening children with coronary artery disease at an early stage so that timely surgery can be possible to save their lives. We recently signed a memorandum of understanding between the government of Chhattisgarh State and HD Medical to screen 77,000 children in Bastar, a remote tribal area.HD Steth enables healthcare workers to screen children with coronary artery disease and refer them for follow-up care in our hospitals.

“HD Steth is very easy to use by non-specialists with minimal training requirements for cardiac auscultation and as a screening tool. We have started a program to screen over 100,000 children in Chickaballapur district in the State of Karnataka in October 2020 and so far we have screened nearly 20,000 children despite COVID-19,” said Dr Satish Babu, a leading endocrinologist trained at Cambridge University Hospital, King’s College Cardiff Hospital and University Hospital UK and currently practices at Sri Sathya Sai Sarla Memorial Hospital, Muddenahalli near Bengaluru, Karnataka.

“We have also expanded the HD Steth screening program to countries such as Fiji, Sri Lanka, Nigeria, Malaysia and the United States,” said Arvind Thiagarajan, Founder and CEO of HD Medical. “These screenings will target 500,000 children within a year, demonstrating HD Medical’s commitment to saving children through early detection of coronary heart disease with better technology.”

For partnerships: [email protected]

About HD Medical, Inc.

HD Medical, Inc. is a Silicon Valley-based innovator of digital health solutions for AI-based cardiovascular disease (CVD) detection and management. HD Steth™ has received FDA clearance (K201299). The company provides smart cardiac care products and solutions worldwide to medical professionals and institutions through channel partners and through the company’s website. Visit www.hdmedicalgroup.com.

Note to editors: HD Steth is a registered trademark of HD Medical, Inc. All other organization names remain the property of their respective owners.